Botanical species · safety record

Vitex trifolia

The EFSA Compendium of Botanicals holds 13 constituent measurements for Vitex trifolia. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Vitex trifolia L.

13Constituent measurements

0Safety records

6Cited sources

57Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 57 licensed products naming Vitex trifolia as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Fruit
Fruit (stir-fired slightly)
Fruit (stir-fried)
Fruit(s)
Ripe fruit(s)
Seed (Stir-baked)
Vitex rotundifolia - Fruit

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Benzaldehyde	Fruit unspecified	Essential oil	1.4 Percent	GC-MS	Resolve DOI
Carvone	Fruit unspecified	Essential oil	10.2 Percent	GC-MS	Resolve DOI
Eugenol	Fruit unspecified	Essential oil	2.8 Percent	GC-MS	Resolve DOI
Isoeugenol	Fruit unspecified	Essential oil	3.2 Percent	GC-MS	Resolve DOI
Labdane diterpenes	Fruit unspecified	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
1,8-cineole	Unspecified	Solvent extraction	—	GC-MS	No resolvable identifier
Anthraquinones	Aerial part of plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Epoxides	Fruit unspecified	Essential oil	—	Mass Spectroscopy and hyphenated methods without chromatography	No resolvable identifier
Indole alkaloids	Fruit unspecified	Solvent extraction	—	GC-MS	No resolvable identifier
Lignans	Aerial part of plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Physcion	Fruit unspecified	Essential oil	—	Mass Spectroscopy and hyphenated methods without chromatography	No resolvable identifier
Saponins	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Tannins	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Thenmozhi, S., Sundaram, R. Shamuga., Kumar, Jena Prabhat., Bihari, Choudhury Golak. Pharmacognostical and phytochemical investigation on leaves of Vitex trifolia Linn. Journal of pharmacy research, 2011, p. 1259-1262.
Hoang, Van Luu. Chemical composition of Vitex trifolia L. Tap chi duoc hoc, 2003, p. 13-14.
Gu, Q., Zhang, X.-M., Jiang, Z.-Y., Chen, J.-J., Zhou, J. Chemical constituents from fruits of Vitex trifolia. Chinese traditional and herbal drugs, 2007, vol. 38, no. 5, p. 656-659.
Zhao, C., Zeng, Y., Wan, M., Li, R., Liang, Y., Li, C., Zeng, Z., Chau, F.-T. Comparative analysis of essential oils from eight herbal medicines with pungent flavor and cool nature by GC-MS and chemometric resolution methods. Journal of separation science, 2009, vol. 32, no. 4, p. 660-670. DOI
Yan, Lihua., Xu, Lizhen., Lin, Jia., Zou, Zhongmei., Liu, Chunyu., Yang, Shilin. Chemical constituents from stems and leaves of Vitex trifolia L. (I). Zhongcaoyao, 2009, p. 531-533.
Li, WX., Cui, CB., Cai, B., Yao, XS. Labdane-type diterpenes as new cell cycle inhibitors and apoptosis inducers from Vitex trifolia L. . Journal of asian natural products research, 2005, vol. 7, no. 2, p. 95-105. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature